目的对喘可治注射液质量标准进行提高。
Objective To improve the quality standard of Chuankezhi injection.
喘可治注射液，他的相似度都是比较好的，他的工艺是比较稳定的，这些在临床用起来就比较放心。
Chuankezhi injection has a high similarity and stable producing technology which make it safe to be used in clinic.
方法喘可治注射液6批，对安全性检查项目的限值进行确定和方法验证，以及进行稳定性考察等实验研究。
Methods the safety inspection limits of 6 different batches Chuankezhi injection were determined, and the methods were verified, and the stability of the method was also determined.
结论喘可治注射液治疗儿童支气管哮喘急性发作期疗效肯定，无毒副作用，并具有一定的预防哮喘复发的作用。
Conclusion: Chuankezhi injection has a certain effect on acute attack of bronchial asthma in children without toxic or side effect, and can prevent the recurrence of asthma to some extent.
结论喘可治注射液治疗儿童支气管哮喘急性发作期疗效肯定，无毒副作用，并具有一定的预防哮喘复发的作用。
Conclusion: Chuankezhi injection has a certain effect on acute attack of bronchial asthma in children without toxic or side effect, and can prevent the recurrence of asthma to some extent.
应用推荐